Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Liver organoid model-based drug hepatotoxicity evaluation method

An evaluation method and organoid technology, applied in the field of biomedicine, can solve the problems of limited practicability and long-term culture capacity, and achieve the effects of reducing the cost of new drug development, easy operation, and reducing labor costs.

Active Publication Date: 2020-11-24
ACCURATE INT BIOTECHNOLOGY (GUANGZHOU) CO LTD
View PDF15 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Hepatoma cell lines and animal models remain the "gold standard" for drug metabolism and toxicity testing, but their utility and long-term culture capabilities are limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liver organoid model-based drug hepatotoxicity evaluation method
  • Liver organoid model-based drug hepatotoxicity evaluation method
  • Liver organoid model-based drug hepatotoxicity evaluation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] This embodiment provides a method for evaluating hepatotoxicity of chloroquine phosphate based on a liver organoid model, comprising the following steps:

[0040] 1. Establishment of mouse liver organoid model:

[0041] 1) Sample cleaning: the mouse liver tissue was washed several times with normal saline containing 1% double antibody, and the obvious fat tissue was removed.

[0042] 2) Sample cutting: Cut the tissue into small pieces of about 0.5mm^3.

[0043] 3) Tissue digestion: ①Disperse the sheared tissue in normal saline, centrifuge to remove the supernatant, add collagenase, dispase and DNaseI to the precipitate, shake and digest at 37°C for 30min, add 1% green chain double antibody The normal saline was used to stop the digestion, and the cell pellet was collected; ②Continue to add collagenase, dispase and DNaseI to the pellet, shake and digest at 37°C for 2 hours, add green chain normal saline containing 1% double antibody to stop the digestion, and let it sta...

Embodiment 2

[0052] This embodiment provides a method for evaluating the hepatotoxicity of mitoxantrone based on a liver organoid model, comprising the following steps:

[0053] 1. Establishment of mouse liver organoid model:

[0054] 1) Sample cleaning: the mouse liver tissue was washed several times with normal saline containing 1% double antibody, and the obvious fat tissue was removed.

[0055] 2) Sample cutting: Cut the tissue into small pieces of about 0.5mm^3.

[0056] 3) Tissue digestion: ①Disperse the sheared tissue in normal saline, centrifuge to remove the supernatant, add collagenase, dispase and DNaseI to the precipitate, shake and digest at 37°C for 30min, add 1% green chain double antibody The normal saline was used to stop the digestion, and the cell pellet was collected; ②Continue to add collagenase, dispase and DNaseI to the pellet, shake and digest at 37°C for 2 hours, add green chain normal saline containing 1% double antibody to stop the digestion, and let it stand P...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a liver organoid model-based drug hepatotoxicity evaluation method. The evaluation method comprises the steps: 1, establishing a mouse liver organoid model: (1) taking mouse liver tissue, and sequentially carrying out cleaning, shearing, digestion, lysis and filtration treatment to obtain mouse liver stem cell precipitate; (2) preparing glue from the mouse liver stem cells,and performing culturing with a culture medium to obtain a liver organoid model; and 2, carrying out drug treatment on the liver organoid model: setting a drug to be detected into a plurality of concentration gradients, then giving drug stimulation under different concentration gradients to the liver organoid model, collecting organoid samples at different time points, observing morphological changes of the organoid samples, and detecting liver function indexes. The invention provides a more accurate method for in-vitro detection of drug hepatotoxicity, which has the advantages of short periodand simple operation, can replace the traditional cell line model and animal model, and is used for preclinical new drug development and clinical drug hepatotoxicity evaluation.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to a drug hepatotoxicity evaluation method based on a liver organoid model. Background technique [0002] The liver's unique metabolic functions and relationship to the gastrointestinal tract make it an important target for drug and xenobiotic toxicity. Changes in liver metabolic activity from birth to adolescence with differential sensitivity to allotoxins. Hepatic drug metabolism, the often unbalanced production and detoxification process of toxic metabolites, can affect the degree of hepatotoxicity. In cases of severe toxicity, patients may develop hepatic failure. Drug-induced liver injury is currently the most common adverse event in the development of new drugs that leads to drug withdrawal due to safety, and liver toxicity discovered after approval for marketing also limits the use of many drugs. It would be a great boon to humans and experimental animals i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/074C12Q1/02
CPCC12N5/0671C12N5/0672C12N2500/32C12N2500/38C12N2500/60C12N2501/11C12N2501/119C12N2501/237C12N2501/345C12N2501/727C12N2513/00G01N33/5014G01N33/5088
Inventor 李刚杨志英陈泽新
Owner ACCURATE INT BIOTECHNOLOGY (GUANGZHOU) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com